Merck's Investigational Drug Could Bring a Once-Monthly Oral Option for HIV PrEP
|
... HIV drugs currently under investigation. The
drugmaker also is researching the other novel drug in this class, islatravir,
which is undergoing ... |
AbbVie's HIV Study: A Potential Game Changer in HIV Treatment
... Antiretroviral Therapy Undergoing Analytical Treatment Interruption. The study aims to assess changes in disease activity, adverse events, and ... View article...